NCT05972785View on ClinicalTrials.gov

Long-term Use of CCB and Breast Cancer Risk

Active, not recruitingOBSERVATIONAL
Enrollment

68,500

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Hypertension,EssentialBreast Cancer
Interventions
DRUG

Calcium channel blocker

Drugs with ATC code C08 will be categorised as calcium channel blockers.

DRUG

Beta blocker

Drugs with ATC code C07 will be categorised as beta-blockers.

DRUG

Diuretic

Drugs with ATC code C03 will be categorised as diuretics.

DRUG

RAS

Drugs with ATC code C09 will be categorised as RAS (agents acting on the renin angiotensin system).

DRUG

Other AHT

Drugs with ATC code C02 will be categorised as other antihypertensives.

DRUG

None AHT

None AHT

Trial Locations (1)

6102

Curtin university, Bentley

All Listed Sponsors
lead

Curtin University

OTHER